China Pharma Holdings Inc
CPHI
View Detailed Chart
0.620USD
-0.010-1.60%
Market hours （ET）Quotes delayed by 15 min
53.98KMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.60%
5 Days
+14.81%
1 Month
+8.20%
6 Months
-68.37%
Year to Date
-48.76%
1 Year
-77.43%
View Detailed Chart
TradingKey Stock Score of China Pharma Holdings Inc
Currency: USD Updated: 2026-03-27Key Insights
China Pharma Holdings Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 124 out of 157 in the Pharmaceuticals industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
China Pharma Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
China Pharma Holdings Inc Highlights
StrengthsRisks
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
Growing
The company is in a growing phase, with the latest annual income totaling USD 4.53M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 4.53M.
Overvalued
The company’s latest PE is -0.62, at a high 3-year percentile range.
Held by James Simons
Star Investor James Simons holds 11.32K shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
China Pharma Holdings Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
China Pharma Holdings Inc Info
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
Ticker SymbolCPHI
CompanyChina Pharma Holdings Inc
CEOLi (Zhilin)
Websitehttp://www.chinapharmaholdings.com
Related Instruments
-0.69%
-0.70%
+0.91%
+3.22%
+0.24%
+0.65%
+0.28%
-0.77%
+0.43%
-0.74%
+1.86%
-0.27%
+0.87%
+0.23%
-2.68%
0.00%
+0.73%
-0.37%
+1.73%
-1.80%Popular Symbols
247.435
-5.455 (-2.16%)
167.060
-0.460 (-0.27%)
67499.510
+915.460 (+1.38%)
260.600
-14.740 (-5.35%)
2061.630
+61.630 (+3.08%)
362.565
+0.735 (+0.20%)
4538.010
+45.490 (+1.01%)
101.172
+0.563 (+0.56%)
1.147
-0.004 (-0.33%)
159.520
-0.732 (-0.46%)
